FOXO3 and acute myeloid leukemia: Results revealed dose-dependent effects: compared to the control group, AML decreased Igf1 and Foxo3 mRNA expression (P < 0.01, Fig. 6A, G), while AMM and AMH increased Igf1 but decreased Pten mRNA expression (P < 0.01, Fig. 6D).